Fellowship ​

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

About Fellowship with AAHMS






Director, School of Medicine and Psychology
Australian National University

Professor Paul Fitzgerald is an academic psychiatrist expert in experimental studies and clinical trials for development of novel treatment options for patients with depression, schizophrenia, OCD, PTSD, autism and Alzheimer’s disease. He is a global authority in repetitive transcranial magnetic stimulation (rTMS).

He’s had continual NHMRC grant support for 20 years and $10+ million in research support in the last five years. He established multiple clinical rTMS services, founded device and clinical service companies and led a national application to MSAC which resulted, in 2021, in Medicare funding ($280 million in year 1) for rTMS therapy for patients with depression.

Professor of Public Health, Head of School, School of Population Health
UNSW Sydney

Professor Rebecca Ivers – Head of the UNSW School of Population Health – is an Australian research leader in the field of public health, with a focus on injury prevention and trauma care research. She has a distinguished track record of research that has significantly advanced our understanding of the burden, prevention and care of injury across the life course. Her research has contributed substantively and substantially to reducing injury in both young and older people, and has led to better, more culturally safe trauma care in Australia and globally.

Chair of Paediatric Anaesthesia
The University of Western Australia

One in 20 children in Australia have surgery each year with 1 in 7 having breathing problems during or after anaesthesia with infants having even a 1 in 3 chance of breathing problems. Unsurprisingly, paediatric anaesthesia is seen as a high-risk specialty which can lead to long-lasting harm, including death. Through several large research projects, Professor Britta Regli-von Ungern-Sternberg has generated new knowledge which led to changes in how anaesthesia for children is performed in Australia and worldwide. Her goal is to ensure that when a child needs a vital operation, it is as safe and pain-free as possible.

Professor of Medicine
The University of Western Australia

Professor Yun Chor Gary Lee is a world leader in Pleural Disease which affects 60,000 Australians/year. His practice-changing work has cut mortality, morbidity, interventions and hospitalization worldwide. Bringing together clinicians, scientists and allied-health researchers, he employs multicentre trials (via the Australasian Malignant PLeural Effusion trials network he built), cross-disciplinary (diet, exercise, psychology) approaches and cutting-edge laboratory techniques to advance pleural effusions (pleurisy) care. He has 320 publications (16 in NEJM, JAMA and Lancet journals), delivered 300+ invited lectures in 32 countries and won $20+ million in grant funding, including NHMRC/MRFF Career Development, Practitioner and Investigator Fellowships.

Director of Research
Austin Health

Professor Catriona Bradshaw is a clinician researcher whose research has led to paradigm shifts in the diagnosis, treatment and control of drug-resistant and refractory sexually transmitted infections. She described the emergence of antibiotic-resistance in Mycoplasma genitalium, and identified new drugs and resistance-guided strategies to improve cure and antibiotic stewardship, which has repeatedly changed guidelines in Australia and internationally (UK/US/Europe/Asia). She has >330 publications and has made sustained contributions to the profession through membership of national/international organisations, guideline and conference-organising committees, peer-review, mentorship and supervision. She is a recipient of the L’Oréal Australia Women in Science Award and Eureka Prize for Infectious Diseases.

Professor, NHMRC Principal Research Fellow
Monash University

Professor Jian Li’s antimicrobial research, clinical translation and commercialisation have provided impactful solutions to combat life-threatening multidrug-resistant bacterial infections globally. Notably, his world-leading research has led to a novel antibiotic drug QPX9003 which was developed intelligently from proof-of-concept to Phase-I trials. Furthermore, his long-term polymyxin pharmacology research has significantly improved clinical practice worldwide. He is a fellow of the American Academy of Microbiology, a Clarivate Highly Cited Researcher, President of the International Society of Anti-infective Pharmacology, and holds multiple other leadership positions in key international societies. Overall, Professor Li has significantly improved the science of antibiotics and human health globally.

Matthew Flinders Distinguished Professor
Flinders University

Professor Jamie Craig, is an ophthalmologist-scientist, is a Matthew Flinders Distinguished Professor and Academic Head of Ophthalmology at Flinders University, and a Senior Consultant at Flinders Medical Centre in Adelaide. An NHMRC Practitioner Fellow (2019-23), his research focusses on the molecular genetics of blinding eye conditions. He conceptualised, established and leads two international ophthalmic disease registers, ANZRAG (advanced glaucoma) and RADAR (diabetic retinopathy), which have identified disease-causal and disease-associated genes, driven changes in clinical practice, and improved patient outcomes. He has published over 390 peer-reviewed articles (>14,400 cites) and is a sought-after supervisor and mentor of young clinicians and scientists.

Professor of Medicine
Kirby Institute, UNSW Sydney

Professor Gail Matthews is Head of the Therapeutic Vaccine and Research Program at the Kirby Institute UNSW, as well as Head of Infectious Diseases at St Vincent’s Hospital, Sydney. Her background is in HIV, viral hepatitis and strategic therapeutic clinical trials, and has expanded over the last 3-years to include a strong research portfolio and leadership role in COVID-19. She is recognised as a leader in her field both nationally and internationally, has led multiple large scale clinical trials (including US NIH), and has just been awarded a NHMRC Investigator Leadership grant (2023-2027), having held two prior Career Development Fellowships.

Broadcaster and Journalist, Science and Health
Australian Broadcasting Corporation

Dr Norman Swan has been Australia’s top health and medical science broadcaster for the last four decades, producing and delivering radio and TV programs across all areas. He is nationally and internationally recognised as an outstanding communicator to educate the public about the latest research in health, disease, treatments and research.

Dr Swan has championed good and criticised bad or unethical research, interviewed researchers and consumers globally, translating the information to improve health literacy and evidence-based choices. During the COVID-19 pandemic, Dr Swan has become an important face and voice of reason for many.

Head, School of Public Health and Preventive Medicine
Monash University

Professor Sophia Zoungas, Head of the School of Public Health and Preventive Medicine at Monash University, is a Clinical Endocrinologist recognised internationally for her role in advancing knowledge in the management of diabetes and its vascular complications. She leads Australia’s largest translational research program in diabetes care and benchmarking of diabetes services.

Professor Zounga’s research has led to improved prescribing for control of glucose and other cardiovascular risk factors among people with diabetes and identified new models of care that promote equity of access to best practice in the Australian community.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

To ensure the Academy has a representative and diverse membership, Fellows nominating two new candidates are asked to include only a maximum of one man, and Fellows nominating four new candidates are asked to include only a maximum of two men.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2023
Newly elected Fellows of 2023 are inducted at the Annual Meeting.

18 September 2023- 30 November 2023
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2023
Nominations allocated to Selection Committees.

January – April 2024
Referees’ reports sought.

Early May 2024
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2024
Council meets to finalise recommendations.

Late July 2024
Full Fellowship invited to comment on recommended new fellows.

August 2024
Election results are shared with proposers and candidates (under embargo).

October 2024
Newly elected Fellows of 2024 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.